Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis.

Cetin, GÜVENOZKAN, TTURGUT, SEDAAli, CikrikciogluCEM, AR MAYER, MUNLU, AKARATOPRAK, CUMALİCELIK, SRSEKIN, Y2019-10-052019-10-052014-10-01Cetin G., OZKAN T., TURGUT S., Ali C., CEM A. M. , AYER M., UNLU A., CELIK S., SEKIN Y., KARATOPRAK C., -Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis.-, Molecular biology reports, cilt.41, ss.6737-42, 2014https://hdl.handle.net/20.500.12645/1783enEvaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis.ArticleWOS:0003424400000458491940018610.1007/s11033-014-3559-x25012914